Guidelines for the Appropriate Use of Cholinesterase Inhibitors in Patients with Alzheimer's Disease

Author： Schachter A.S.   Davis K.L.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.11, Iss.4, 1999-04, pp. : 281-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholinesterase Inhibitors for Alzheimer's Disease

By Grutzendler J.   Morris J.C.  

Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. : 41-52

Adis International

Access to resources Recommend Favorite

Pharmacodynamic-Tolerability Relationships of Cholinesterase Inhibitors for Alzheimer's Disease

By Imbimbo B.P.  

CNS Drugs, Vol. 15, Iss. 5, 2001-01 ,pp. : 375-390

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

By Jönsson L.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease in the Elderly

By vandenBerg C.M.   Kazmi Y.   Jann M.W.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 123-138

Adis International

Access to resources Recommend Favorite

Drug Persistency of Two Cholinesterase Inhibitors: Rivastigmine versus Donepezil in Elderly Patients with Alzheimer’s Disease

By Suh Dong-Churl  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 695-707

Adis International

Access to resources Recommend Favorite